Viemed HealthcareVMD +0.54%93 PB Ratio is 3.25 as of Jul. 08, 2026, which is 6% above its 10-year median of 3.07. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.90 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Viemed Healthcare ranks worse than 66.58% on this metric.
Viemed Healthcare Inc stock PB Ratio (=3.23) is close to 3-year high of 3.44.
The historical rank and industry rank for Viemed Healthcare's PB Ratio or its related term are showing as below:
VMD'
s PB Ratio Range Over the Past 10 Years
Min: 1.56 Med: 3.07 Max: 8.9
Current: 3.25
During the past 10 years, Viemed Healthcare's highest PB Ratio was 8.90. The lowest was 1.56. And the median was 3.07.
VMD's PB Ratio is ranked worse than 66.58% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs VMD: 3.25
During the past 12 months, Viemed Healthcare's average Book Value Per Share Growth Rate was 9.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 12.30% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Viemed Healthcare was 50.20% per year. The lowest was 12.00% per year. And the median was 30.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Viemed Healthcare PB Ratio Related Terms
Viemed Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Viemed Healthcare (VMD) has a PB Ratio of 3.25 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Viemed Healthcare and its competitors. This is near median its historical median of 3.07. Over the past decade, Viemed Healthcare's PB Ratio has ranged from 1.56 to 8.90. According to the industry distribution chart, Viemed Healthcare ranks #524 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 66.6%.
Is Viemed Healthcare's PB Ratio too high?
Viemed Healthcare's current PB Ratio of 3.25 is near median its 10-year median of 3.07. Over the past 10 years, this metric has ranged from a low of 1.56 to a high of 8.90. The Medical Devices & Instruments industry median PB Ratio is 2.06. Viemed Healthcare's value of 3.25 is 57.8% above this industry median. Based on the distribution chart, Viemed Healthcare ranks #524 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's PB Ratio compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #524 out of 787 companies for PB Ratio. This places Viemed Healthcare in the lower half of its industry. The industry median PB Ratio is 2.06. Viemed Healthcare's value of 3.25 is 57.8% above this benchmark. Historically, Viemed Healthcare's own PB Ratio has ranged from 1.56 to 8.90 over the past decade. While the company's 10-year median is 3.07 vs. the industry median of 2.06, Viemed Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current PB Ratio of 3.25 is 57.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current PB Ratio is 3.25, which is near median its own 10-year median of 3.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.90, compared to a current price of $12.14 — trading 11.4% above its estimated fair value. The current PB Ratio is 3.25, which is near median its 10-year median of 3.07 and 57.8% above the Medical Devices & Instruments industry median of 2.06. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current PB Ratio is 3.25 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of $12.14 is trading 11.4% above its estimated GF Value™ of $10.90.
GuruFocus considers Viemed Healthcare to be Modestly Overvalued.
Key valuation signals for VMD:
PB Ratio: 3.25 (near median its 10-year median of 3.07)
GF Value™: $10.90 vs. price of $12.14 (11.4% above fair value)
Industry Position: 57.8% above the Medical Devices & Instruments median (#524 of 787)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score
Get the complete analysis for VMD
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
